Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin.

Yan LH, Chen ZN, Li-Li, Chen J, Wei WE, Mo XW, Qin YZ, Lin Y, Chen JS

DOI: 10.18632/oncotarget.28835
Published: 2026 Jan 6
Container: Oncotarget
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.28835,
  title = {Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin.},
  author = {Yan LH and Chen ZN and Li-Li and Chen J and Wei WE and Mo XW and Qin YZ and Lin Y and Chen JS},
  year = {2026},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.28835},
  url = {https://doi.org/10.18632/oncotarget.28835}
}

RIS

TY  - JOUR
TI  - Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
AU  - Yan LH
AU  - Chen ZN
AU  - Li-Li
AU  - Chen J
AU  - Wei WE
AU  - Mo XW
AU  - Qin YZ
AU  - Lin Y
AU  - Chen JS
PY  - 2026
JO  - Oncotarget
DO  - 10.18632/oncotarget.28835
UR  - https://doi.org/10.18632/oncotarget.28835
ER  -

APA

LH, Y., ZN, C., Li-Li, J, C., WE, W., XW, M., YZ, Q., Y, L., & JS, C. (2026). Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin.. Oncotarget. https://doi.org/10.18632/oncotarget.28835

Source records

pubmed · retrieved 2026-09-25T11:17:08.293Z